ProQR Therapeutics (PRQR) Share-based Compensation Growth (1y) (2014 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -119.38% |
| Sep 30, 2022 | -33.48% |
| Jun 30, 2022 | -55.55% |
| Mar 31, 2022 | -11.80% |
| Dec 31, 2021 | 14.69% |
| Sep 30, 2021 | 3.37% |
| Jun 30, 2021 | -10.75% |
| Mar 31, 2021 | 47,413.82% |
| Dec 31, 2020 | -64.29% |
| Sep 30, 2020 | 43.50% |
| Jun 30, 2020 | 60.58% |
| Mar 31, 2020 | -99.88% |
| Dec 31, 2019 | 137,467.21% |
| Sep 30, 2019 | 59.79% |
| Jun 30, 2019 | 61.82% |
| Mar 31, 2019 | 242,935.54% |
| Dec 31, 2018 | 228.81% |
| Sep 30, 2018 | 81,534.32% |
| Jun 30, 2018 | -45.43% |
| Mar 31, 2018 | 8.35% |
| Dec 31, 2017 | -99.96% |
| Sep 30, 2017 | 49.20% |
| Dec 31, 2016 | 99.44% |
| Sep 30, 2016 | 110.07% |
| Dec 31, 2015 | 342.55% |
| Sep 30, 2015 | -99.86% |
| Mar 31, 2015 | 128.32% |
| Dec 31, 2014 | 465.08% |
| Sep 30, 2014 | 8,815.13% |